Oral resveratrol supplementation improves Metabolic Syndrome features in obese patients submitted to a lifestyle-changing program
The aim of the present study was to evaluate the oral resveratrol effects associated with diet and physical training changes on anthropometric and biochemical parameters. 25 individuals aged from 30 to 60 years old; with Body Mass Index (BMI) ≥ 30 kg/m2 were included in the study. Following the prim...
Gespeichert in:
| Veröffentlicht in: | Life sciences (1973) 2020-09, Vol.256, p.117962, Article 117962 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | 117962 |
| container_title | Life sciences (1973) |
| container_volume | 256 |
| creator | Batista-Jorge, G.C. Barcala-Jorge, A.S. Silveira, M.F. Lelis, D.F. Andrade, J.M.O. de Paula, A.M.B. Guimarães, A.L.S. Santos, S.H.S. |
| description | The aim of the present study was to evaluate the oral resveratrol effects associated with diet and physical training changes on anthropometric and biochemical parameters.
25 individuals aged from 30 to 60 years old; with Body Mass Index (BMI) ≥ 30 kg/m2 were included in the study. Following the primary evaluation (anthropometric and clinical), the patients were randomly divided into 2 groups: (1) Placebo: Physical activity program + Diet + Placebo; (2) Resveratrol: Physical activity program + Diet + Resveratrol (RVS) (250 mg/day) for three months. Anthropometric and biochemical parameters were evaluated at baseline and after the treatment period.
The main findings showed that the resveratrol supplementation improved total cholesterol (TC), High-density Lipoprotein cholesterol (HDL-c), Very-low density Lipoprotein cholesterol (VLDL-c), urea, creatinine and albumin serum levels.
These findings indicate that this polyphenol may be an option to potentiate the beneficial effects induced by dietary and physical activity programs in the Metabolic Syndrome (MetS) treatment. |
| doi_str_mv | 10.1016/j.lfs.2020.117962 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_2506752947</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0024320520307128</els_id><sourcerecordid>2506752947</sourcerecordid><originalsourceid>FETCH-LOGICAL-c401t-2abc27d8f3833d27780eb458ad8567e3ac1e69a8441233b4948aa0bb681f7e593</originalsourceid><addsrcrecordid>eNp9kMtKxDAUhoMoOF4ewF3Adcdc2ibFlQzeYGQW6jqk6emY0jY1yQzM0jc3Q127Ohw43_8fPoRuKFlSQsu7btm3YckISzsVVclO0IJKUWWk5PQULQhhecYZKc7RRQgdIaQoBF-gn43XPfYQ9uB19K7HYTdNPQwwRh2tG7EdJu_2EPAbRF273hr8fhgb7wbALei4SzC2I3Y1BMBTghIaUkw92BihwdFhjXvbQoiHHjLzpcetHbc4xW69Hq7QWav7ANd_8xJ9Pj1-rF6y9eb5dfWwzkxOaMyYrg0TjWy55LxhQkgCdV5I3ciiFMC1oVBWWuY5ZZzXeZVLrUldl5K2AoqKX6LbOTf1fu_SM6pzOz-mSsUKUoqCVblIV3S-Mt6F4KFVk7eD9gdFiTqaVp1KptXRtJpNJ-Z-ZiC9v7fgVTBJgoHGejBRNc7-Q_8CYWSJQQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2506752947</pqid></control><display><type>article</type><title>Oral resveratrol supplementation improves Metabolic Syndrome features in obese patients submitted to a lifestyle-changing program</title><source>Elsevier ScienceDirect Journals Complete</source><creator>Batista-Jorge, G.C. ; Barcala-Jorge, A.S. ; Silveira, M.F. ; Lelis, D.F. ; Andrade, J.M.O. ; de Paula, A.M.B. ; Guimarães, A.L.S. ; Santos, S.H.S.</creator><creatorcontrib>Batista-Jorge, G.C. ; Barcala-Jorge, A.S. ; Silveira, M.F. ; Lelis, D.F. ; Andrade, J.M.O. ; de Paula, A.M.B. ; Guimarães, A.L.S. ; Santos, S.H.S.</creatorcontrib><description>The aim of the present study was to evaluate the oral resveratrol effects associated with diet and physical training changes on anthropometric and biochemical parameters.
25 individuals aged from 30 to 60 years old; with Body Mass Index (BMI) ≥ 30 kg/m2 were included in the study. Following the primary evaluation (anthropometric and clinical), the patients were randomly divided into 2 groups: (1) Placebo: Physical activity program + Diet + Placebo; (2) Resveratrol: Physical activity program + Diet + Resveratrol (RVS) (250 mg/day) for three months. Anthropometric and biochemical parameters were evaluated at baseline and after the treatment period.
The main findings showed that the resveratrol supplementation improved total cholesterol (TC), High-density Lipoprotein cholesterol (HDL-c), Very-low density Lipoprotein cholesterol (VLDL-c), urea, creatinine and albumin serum levels.
These findings indicate that this polyphenol may be an option to potentiate the beneficial effects induced by dietary and physical activity programs in the Metabolic Syndrome (MetS) treatment.</description><identifier>ISSN: 0024-3205</identifier><identifier>EISSN: 1879-0631</identifier><identifier>DOI: 10.1016/j.lfs.2020.117962</identifier><language>eng</language><publisher>New York: Elsevier Inc</publisher><subject>Adipose tissue ; Albumins ; Anthropometry ; Body mass ; Body mass index ; Body size ; Cholesterol ; Creatinine ; Density ; Diabetes ; Diet ; Dietary supplements ; Health services ; High density lipoprotein ; Lipoproteins (very low density) ; Low density lipoprotein ; Metabolic disorders ; Metabolic syndrome ; MetS ; Obesity ; Parameters ; Patients ; Physical activity ; Physical training ; Placebos ; Polyphenols ; Resveratrol ; Serum levels ; Sirt1 ; Sirtuins ; Urea</subject><ispartof>Life sciences (1973), 2020-09, Vol.256, p.117962, Article 117962</ispartof><rights>2020 Elsevier Inc.</rights><rights>Copyright Elsevier BV Sep 1, 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c401t-2abc27d8f3833d27780eb458ad8567e3ac1e69a8441233b4948aa0bb681f7e593</citedby><cites>FETCH-LOGICAL-c401t-2abc27d8f3833d27780eb458ad8567e3ac1e69a8441233b4948aa0bb681f7e593</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.lfs.2020.117962$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids></links><search><creatorcontrib>Batista-Jorge, G.C.</creatorcontrib><creatorcontrib>Barcala-Jorge, A.S.</creatorcontrib><creatorcontrib>Silveira, M.F.</creatorcontrib><creatorcontrib>Lelis, D.F.</creatorcontrib><creatorcontrib>Andrade, J.M.O.</creatorcontrib><creatorcontrib>de Paula, A.M.B.</creatorcontrib><creatorcontrib>Guimarães, A.L.S.</creatorcontrib><creatorcontrib>Santos, S.H.S.</creatorcontrib><title>Oral resveratrol supplementation improves Metabolic Syndrome features in obese patients submitted to a lifestyle-changing program</title><title>Life sciences (1973)</title><description>The aim of the present study was to evaluate the oral resveratrol effects associated with diet and physical training changes on anthropometric and biochemical parameters.
25 individuals aged from 30 to 60 years old; with Body Mass Index (BMI) ≥ 30 kg/m2 were included in the study. Following the primary evaluation (anthropometric and clinical), the patients were randomly divided into 2 groups: (1) Placebo: Physical activity program + Diet + Placebo; (2) Resveratrol: Physical activity program + Diet + Resveratrol (RVS) (250 mg/day) for three months. Anthropometric and biochemical parameters were evaluated at baseline and after the treatment period.
The main findings showed that the resveratrol supplementation improved total cholesterol (TC), High-density Lipoprotein cholesterol (HDL-c), Very-low density Lipoprotein cholesterol (VLDL-c), urea, creatinine and albumin serum levels.
These findings indicate that this polyphenol may be an option to potentiate the beneficial effects induced by dietary and physical activity programs in the Metabolic Syndrome (MetS) treatment.</description><subject>Adipose tissue</subject><subject>Albumins</subject><subject>Anthropometry</subject><subject>Body mass</subject><subject>Body mass index</subject><subject>Body size</subject><subject>Cholesterol</subject><subject>Creatinine</subject><subject>Density</subject><subject>Diabetes</subject><subject>Diet</subject><subject>Dietary supplements</subject><subject>Health services</subject><subject>High density lipoprotein</subject><subject>Lipoproteins (very low density)</subject><subject>Low density lipoprotein</subject><subject>Metabolic disorders</subject><subject>Metabolic syndrome</subject><subject>MetS</subject><subject>Obesity</subject><subject>Parameters</subject><subject>Patients</subject><subject>Physical activity</subject><subject>Physical training</subject><subject>Placebos</subject><subject>Polyphenols</subject><subject>Resveratrol</subject><subject>Serum levels</subject><subject>Sirt1</subject><subject>Sirtuins</subject><subject>Urea</subject><issn>0024-3205</issn><issn>1879-0631</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNp9kMtKxDAUhoMoOF4ewF3Adcdc2ibFlQzeYGQW6jqk6emY0jY1yQzM0jc3Q127Ohw43_8fPoRuKFlSQsu7btm3YckISzsVVclO0IJKUWWk5PQULQhhecYZKc7RRQgdIaQoBF-gn43XPfYQ9uB19K7HYTdNPQwwRh2tG7EdJu_2EPAbRF273hr8fhgb7wbALei4SzC2I3Y1BMBTghIaUkw92BihwdFhjXvbQoiHHjLzpcetHbc4xW69Hq7QWav7ANd_8xJ9Pj1-rF6y9eb5dfWwzkxOaMyYrg0TjWy55LxhQkgCdV5I3ciiFMC1oVBWWuY5ZZzXeZVLrUldl5K2AoqKX6LbOTf1fu_SM6pzOz-mSsUKUoqCVblIV3S-Mt6F4KFVk7eD9gdFiTqaVp1KptXRtJpNJ-Z-ZiC9v7fgVTBJgoHGejBRNc7-Q_8CYWSJQQ</recordid><startdate>20200901</startdate><enddate>20200901</enddate><creator>Batista-Jorge, G.C.</creator><creator>Barcala-Jorge, A.S.</creator><creator>Silveira, M.F.</creator><creator>Lelis, D.F.</creator><creator>Andrade, J.M.O.</creator><creator>de Paula, A.M.B.</creator><creator>Guimarães, A.L.S.</creator><creator>Santos, S.H.S.</creator><general>Elsevier Inc</general><general>Elsevier BV</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7QR</scope><scope>7TK</scope><scope>7U7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope><scope>RC3</scope></search><sort><creationdate>20200901</creationdate><title>Oral resveratrol supplementation improves Metabolic Syndrome features in obese patients submitted to a lifestyle-changing program</title><author>Batista-Jorge, G.C. ; Barcala-Jorge, A.S. ; Silveira, M.F. ; Lelis, D.F. ; Andrade, J.M.O. ; de Paula, A.M.B. ; Guimarães, A.L.S. ; Santos, S.H.S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c401t-2abc27d8f3833d27780eb458ad8567e3ac1e69a8441233b4948aa0bb681f7e593</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Adipose tissue</topic><topic>Albumins</topic><topic>Anthropometry</topic><topic>Body mass</topic><topic>Body mass index</topic><topic>Body size</topic><topic>Cholesterol</topic><topic>Creatinine</topic><topic>Density</topic><topic>Diabetes</topic><topic>Diet</topic><topic>Dietary supplements</topic><topic>Health services</topic><topic>High density lipoprotein</topic><topic>Lipoproteins (very low density)</topic><topic>Low density lipoprotein</topic><topic>Metabolic disorders</topic><topic>Metabolic syndrome</topic><topic>MetS</topic><topic>Obesity</topic><topic>Parameters</topic><topic>Patients</topic><topic>Physical activity</topic><topic>Physical training</topic><topic>Placebos</topic><topic>Polyphenols</topic><topic>Resveratrol</topic><topic>Serum levels</topic><topic>Sirt1</topic><topic>Sirtuins</topic><topic>Urea</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Batista-Jorge, G.C.</creatorcontrib><creatorcontrib>Barcala-Jorge, A.S.</creatorcontrib><creatorcontrib>Silveira, M.F.</creatorcontrib><creatorcontrib>Lelis, D.F.</creatorcontrib><creatorcontrib>Andrade, J.M.O.</creatorcontrib><creatorcontrib>de Paula, A.M.B.</creatorcontrib><creatorcontrib>Guimarães, A.L.S.</creatorcontrib><creatorcontrib>Santos, S.H.S.</creatorcontrib><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><jtitle>Life sciences (1973)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Batista-Jorge, G.C.</au><au>Barcala-Jorge, A.S.</au><au>Silveira, M.F.</au><au>Lelis, D.F.</au><au>Andrade, J.M.O.</au><au>de Paula, A.M.B.</au><au>Guimarães, A.L.S.</au><au>Santos, S.H.S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Oral resveratrol supplementation improves Metabolic Syndrome features in obese patients submitted to a lifestyle-changing program</atitle><jtitle>Life sciences (1973)</jtitle><date>2020-09-01</date><risdate>2020</risdate><volume>256</volume><spage>117962</spage><pages>117962-</pages><artnum>117962</artnum><issn>0024-3205</issn><eissn>1879-0631</eissn><abstract>The aim of the present study was to evaluate the oral resveratrol effects associated with diet and physical training changes on anthropometric and biochemical parameters.
25 individuals aged from 30 to 60 years old; with Body Mass Index (BMI) ≥ 30 kg/m2 were included in the study. Following the primary evaluation (anthropometric and clinical), the patients were randomly divided into 2 groups: (1) Placebo: Physical activity program + Diet + Placebo; (2) Resveratrol: Physical activity program + Diet + Resveratrol (RVS) (250 mg/day) for three months. Anthropometric and biochemical parameters were evaluated at baseline and after the treatment period.
The main findings showed that the resveratrol supplementation improved total cholesterol (TC), High-density Lipoprotein cholesterol (HDL-c), Very-low density Lipoprotein cholesterol (VLDL-c), urea, creatinine and albumin serum levels.
These findings indicate that this polyphenol may be an option to potentiate the beneficial effects induced by dietary and physical activity programs in the Metabolic Syndrome (MetS) treatment.</abstract><cop>New York</cop><pub>Elsevier Inc</pub><doi>10.1016/j.lfs.2020.117962</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0024-3205 |
| ispartof | Life sciences (1973), 2020-09, Vol.256, p.117962, Article 117962 |
| issn | 0024-3205 1879-0631 |
| language | eng |
| recordid | cdi_proquest_journals_2506752947 |
| source | Elsevier ScienceDirect Journals Complete |
| subjects | Adipose tissue Albumins Anthropometry Body mass Body mass index Body size Cholesterol Creatinine Density Diabetes Diet Dietary supplements Health services High density lipoprotein Lipoproteins (very low density) Low density lipoprotein Metabolic disorders Metabolic syndrome MetS Obesity Parameters Patients Physical activity Physical training Placebos Polyphenols Resveratrol Serum levels Sirt1 Sirtuins Urea |
| title | Oral resveratrol supplementation improves Metabolic Syndrome features in obese patients submitted to a lifestyle-changing program |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T01%3A01%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Oral%20resveratrol%20supplementation%20improves%20Metabolic%20Syndrome%20features%20in%20obese%20patients%20submitted%20to%20a%20lifestyle-changing%20program&rft.jtitle=Life%20sciences%20(1973)&rft.au=Batista-Jorge,%20G.C.&rft.date=2020-09-01&rft.volume=256&rft.spage=117962&rft.pages=117962-&rft.artnum=117962&rft.issn=0024-3205&rft.eissn=1879-0631&rft_id=info:doi/10.1016/j.lfs.2020.117962&rft_dat=%3Cproquest_cross%3E2506752947%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2506752947&rft_id=info:pmid/&rft_els_id=S0024320520307128&rfr_iscdi=true |